The blood brain barrier problem with oral GABA
GABA is the brain's main inhibitory neurotransmitter, so swallowing it seems like a direct route to calm. The difficulty is the blood brain barrier, the selective lining of brain capillaries that limits which molecules reach neural tissue. GABA is a small, charged molecule that crosses this barrier poorly, so most oral GABA does not reach the brain in meaningful amounts. Any calming effect some users report is debated and may involve the gut nervous system or expectation rather than central GABA-A activation.
This is why supplement formulators often look past GABA itself toward molecules that either cross the barrier or act on the GABA system indirectly.
Why precursors and modulators are used instead
Approaches that target the GABA system more effectively include precursors and cofactors involved in GABA synthesis, and modulators such as certain herbal flavones that bind the GABA-A receptor from outside. These work on the brain's own GABA machinery rather than trying to deliver GABA directly, which sidesteps the barrier problem, though their human effects are generally modest.
This is general educational information, not medical advice. Anyone considering these supplements, especially with sedatives or psychiatric medication, should consult a qualified professional.